JP2010506887A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010506887A5 JP2010506887A5 JP2009532837A JP2009532837A JP2010506887A5 JP 2010506887 A5 JP2010506887 A5 JP 2010506887A5 JP 2009532837 A JP2009532837 A JP 2009532837A JP 2009532837 A JP2009532837 A JP 2009532837A JP 2010506887 A5 JP2010506887 A5 JP 2010506887A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- motomeko
- citrulline
- composition according
- intestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline zwitterion Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 208000002720 Malnutrition Diseases 0.000 claims 3
- 229960002173 citrulline Drugs 0.000 claims 3
- 230000004064 dysfunction Effects 0.000 claims 3
- 230000000968 intestinal Effects 0.000 claims 3
- 235000016709 nutrition Nutrition 0.000 claims 3
- 238000001243 protein synthesis Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 230000014616 translation Effects 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 235000000824 malnutrition Nutrition 0.000 claims 2
- 230000001071 malnutrition Effects 0.000 claims 2
- 230000035764 nutrition Effects 0.000 claims 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 210000003414 Extremities Anatomy 0.000 claims 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- 210000003205 Muscles Anatomy 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 229960003104 Ornithine Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002638 denervation Effects 0.000 claims 1
- 210000002249 digestive system Anatomy 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 235000018343 nutrient deficiency Nutrition 0.000 claims 1
- 201000008875 nutrition disease Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 235000016236 parenteral nutrition Nutrition 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
- BKAJNAXTPSGJCU-UHFFFAOYSA-N α-Ketoisocaproic acid Chemical compound CC(C)CC(=O)C(O)=O BKAJNAXTPSGJCU-UHFFFAOYSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N NC(CCCNC(N)=O)C(O)=O Chemical compound NC(CCCNC(N)=O)C(O)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
Claims (8)
- 腸の機能不全に起因しない病状の枠内でタンパク質合成の低下に関連する栄養不足状態にある患者で異常に低い場合の筋肉内タンパク質合成を増大させることを意図する請求項1に記載の医薬組成物。
- 不十分な摂取に関連するタンパク質エネルギー栄養障害、
腸の機能不全を導く腸癌を除く癌、
筋肉の除神経、
腸のレベルで作用するものを除く化学療法、
糖尿病、
肥満、
体重減少、
骨折後の固定化された肢、
腸消化系の外科手術を除く調節された外科手術、及び
栄養失調症
を含む群から選択される疾患又は病状の治療用の請求項1又は2に記載の医薬組成物。 - 医薬組成物が、活性物質として、L-シトルリン又はその医薬的の許容される塩を、医薬的に許容される賦形剤とともに含むことを特徴とする請求項1〜3のいずれか1項に記載の医薬組成物。
- L-シトルリンの単位用量が、0.1g/kg/日〜0.5 g/kg/日の投与量計画について、2g〜20gであることを特徴とする請求項1〜4のいずれか1項に記載の医薬組成物。
- 医薬組成物が、乾燥組成物又は水溶液の形態であることを特徴とする請求項1〜5のいずれか1項に記載の医薬組成物。
- 医薬組成物が、経口、皮下、経腸又は非経口投与され得る請求項1〜6のいずれか1項に記載の医薬組成物。
- 医薬組成物が、単独、又は非経口栄養摂取用の栄養混合物、又は経腸栄養摂取用の混合物、又は経口栄養摂取用の混合物で、ロイシン、グルタミン、アルギニン、オルニチン及びα-ケトグルタレート又はα-ケトイソカプロエートを含むそれらの種々の用い得る塩を含む、栄養不足に関連する悪液質の治療のための1つ又はいくつかのその他の化合物も含む請求項1〜7のいずれか1項に記載の医薬組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609077A FR2907011B1 (fr) | 2006-10-17 | 2006-10-17 | Utilisation de la citrulline pour le traitement des etats de denutrition |
PCT/FR2007/001407 WO2008049984A2 (fr) | 2006-10-17 | 2007-08-29 | Utilisation de la citrulline pour le traitement des etats de denutrition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010506887A JP2010506887A (ja) | 2010-03-04 |
JP2010506887A5 true JP2010506887A5 (ja) | 2010-08-05 |
Family
ID=37888135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009532837A Pending JP2010506887A (ja) | 2006-10-17 | 2007-08-29 | 栄養不足状態の治療のためのシトルリンの使用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100298437A1 (ja) |
EP (1) | EP2081564B1 (ja) |
JP (1) | JP2010506887A (ja) |
CN (1) | CN101605538A (ja) |
CA (1) | CA2666538A1 (ja) |
FR (1) | FR2907011B1 (ja) |
IL (1) | IL198182A0 (ja) |
WO (1) | WO2008049984A2 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
DE102007016715A1 (de) * | 2007-04-04 | 2008-10-09 | Evonik Degussa Gmbh | Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren |
WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
FR2970414B1 (fr) | 2011-01-14 | 2013-03-22 | Univ Paris Descartes | Action preventive de la citrulline sur le developpement spontane des tumeurs |
LT3021690T (lt) | 2013-06-10 | 2017-07-10 | N.V. Nutricia | Raumenų išsaugojimas viršsvorį turintiems arba nutukusiems suaugusiams svorio metimo programos metu |
FR3009963B1 (fr) | 2013-09-03 | 2017-03-03 | Biolis | Composition de lutte contre les troubles de la locomotion |
EP2875736B1 (en) | 2013-11-26 | 2016-07-27 | Citrage | N-Carbamoylputrescine to enhance muscle protein synthesis |
JPWO2015137387A1 (ja) * | 2014-03-11 | 2017-04-06 | 協和発酵バイオ株式会社 | 筋肉増強剤 |
CN104263550A (zh) * | 2014-09-11 | 2015-01-07 | 滁州斯迈特复合材料有限公司 | 化妆液玻璃瓶清洁剂 |
EP3345595B1 (en) * | 2015-09-04 | 2020-04-08 | University of Tsukuba | Composition for muscle building and method for building muscle |
KR102396603B1 (ko) | 2015-09-16 | 2022-05-11 | 원광대학교산학협력단 | 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물 |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
CN108473384A (zh) | 2015-10-27 | 2018-08-31 | 细胞酶动物营养品公司 | 动物营养成分及相关方法 |
AU2018415594A1 (en) | 2018-03-27 | 2020-10-29 | N.V. Nutricia | Insulin control in overweight or obese adult during life time intervention |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6306M (ja) * | 1966-12-15 | 1968-09-16 | ||
FR6305M (ja) * | 1966-12-15 | 1968-09-16 | ||
FR6304M (ja) * | 1966-12-15 | 1968-09-16 | ||
US5189025A (en) * | 1988-12-09 | 1993-02-23 | Board Of Regenets, The University Of Texas System | Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions |
US4988724A (en) * | 1988-12-09 | 1991-01-29 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
FR2691359B1 (fr) * | 1992-05-20 | 1995-06-23 | Krempf Michel | Nouvelle application therapeutique du malate de 1-citrulline. |
US20010056068A1 (en) * | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
US9486429B2 (en) * | 1999-06-01 | 2016-11-08 | Vanderbilt University | Therapeutic methods employing nitric oxide precursors |
FR2857262B1 (fr) * | 2003-07-08 | 2007-10-05 | Biocodex Lab | Utilisation de la citrulline dans le cadre de l'insuffisance intestinale |
-
2006
- 2006-10-17 FR FR0609077A patent/FR2907011B1/fr not_active Expired - Fee Related
-
2007
- 2007-08-29 JP JP2009532837A patent/JP2010506887A/ja active Pending
- 2007-08-29 EP EP07823453.1A patent/EP2081564B1/fr active Active
- 2007-08-29 CN CNA2007800424825A patent/CN101605538A/zh active Pending
- 2007-08-29 WO PCT/FR2007/001407 patent/WO2008049984A2/fr active Application Filing
- 2007-08-29 CA CA002666538A patent/CA2666538A1/fr not_active Abandoned
- 2007-08-29 US US12/445,820 patent/US20100298437A1/en not_active Abandoned
-
2009
- 2009-04-16 IL IL198182A patent/IL198182A0/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010506887A5 (ja) | ||
CN102625699A (zh) | 使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能 | |
CN108245496A (zh) | 虾青素抗炎增效组合 | |
WO2015144965A1 (es) | Preparación duradera de inyectable de melatonina estable a largo plazo | |
RU2010129825A (ru) | Материалы и способы для лечения патологической пролиферации глазных сосудов | |
CN111295102A (zh) | 氨基酸补充剂在提高肌肉蛋白质合成中的用途 | |
JP5177785B2 (ja) | 周術期患者用薬剤 | |
KR100852930B1 (ko) | 체온 상승성 아미노산군 의료용 제제 | |
WO2014038630A1 (ja) | セシウム排泄剤、有害金属排泄剤、飲食品、飼料および医薬品 | |
WO2009149196A1 (en) | Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same | |
TWI606826B (zh) | 艾拉莫德或其鹽之用途 | |
JP2010532348A5 (ja) | ||
CN107137417B (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
WO2014026557A1 (zh) | 3-氨基-1-丙烷磺酸及其衍生物在制备治疗心脑血管或神经退行性疾病的药物中的应用 | |
CN109833481B (zh) | 一种阿利沙坦酯或其盐与利尿剂的药物组合物 | |
CN104114165B (zh) | 用于治疗憩室病的方法和组合物 | |
ES2641143T3 (es) | Una composición farmacéutica que comprende palmitoiletanolamida y citidina-difosfocolina | |
WO2010081266A1 (zh) | 延胡索乙素的新用途 | |
CN105832759B (zh) | 一种预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病的药物组合物 | |
WO2011085701A1 (zh) | 稳定的蛋白激酶激活剂及其制备方法和用途 | |
JP6100510B2 (ja) | 抗感冒剤 | |
ES2268452T3 (es) | Agente con efecto destructivo en tumores malignos asi como procedimiento para su produccion. | |
JPH06172187A (ja) | 筋ジストロフィー症治療薬 | |
JPWO2021023811A5 (ja) | ||
RU2777605C2 (ru) | Применение аминокислотной добавки для улучшенного синтеза мышечного белка |